Terumo Corporation (TRUMY) Stock Analysis & Winston Score
Terumo Corporation is a Japanese medical device company that makes equipment used inside hospitals and clinics. Its main products include blood bags, syringes, catheters, and devices used in heart surgeries and blood vessel procedures. Terumo sells to hospitals, blood banks, and healthcare systems around the world, and it is one of Japan's largest medical device makers. Terumo earns money by selling its medical products directly to healthcare providers and through long-term supply relationships with hospitals. The company operates globally, with significant revenue coming from Japan, the United States, Europe, and Asia. Its moat comes from strong regulatory approvals, trusted brand relationships with hospitals, and specialized manufacturing know-how that takes years to replicate. The key growth driver is expanding its cardiovascular and interventional device business, particularly in the U.S. and emerging markets, though currency fluctuations and pricing pressure from hospital procurement systems remain ongoing risks.
Winston Score: 50/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (11/30)
- Growth: Mixed (6/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (10/10)
- Valuation: Strong (7/10)
- Ownership: Mixed (6/15)
Key Facts
Price: $13.96
Market Cap: $20.6B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: Other OTC



